In his weekly roundup for Oppenheimer & Co., Carl McDonald speculated: “If WellPoint isn’t granted something close to the rate increase they are requesting, we wouldn’t be surprised to see the company exit the individual market in the state. Doing so would send a message to state regulators across the country that they can only go so far in limiting plan rate increases before plans are no longer willing to remain in the market.”

So goes Maine.

If you'd like to get email from CJR writers and editors, add your email address to our newsletter roll and we'll be in touch.

Trudy Lieberman is a fellow at the Center for Advancing Health and a longtime contributing editor to the Columbia Journalism Review. She is the lead writer for The Second Opinion, CJR’s healthcare desk, which is part of our United States Project on the coverage of politics and policy. Follow her on Twitter @Trudy_Lieberman.